{
  "id": 9170637,
  "title": "Vertex aims for broad kidney disease label ahead of key readout next year",
  "url": "https://urgent.news/2026/09/22/vertex-aims-for-broad-kidney-disease-label-ahead-of-key-readout-next",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T17:45:50.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/vertex-aims-for-broad-kidney-disease-label-ahead-of-key-readout-next-year/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Vertex Pharmaceuticals reported that an experimental kidney disease drug called inaxaplin improved measures on a urine test in two different patient populations, raising optimism ahead of the company’s upcoming pivotal readout. ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}